Must-See Earnings Estimates for: Zomedica (NYSEAMERICAN:ZOM)

Earnings results for Zomedica (NYSEAMERICAN:ZOM)

Zomedica Corp. is estimated to report earnings on 02/24/2021. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for the quarter is $0. The reported EPS for the same quarter last year was $-0.03.

Analyst Opinion on Zomedica (NYSEAMERICAN:ZOM)

1 Wall Street analysts have issued ratings and price targets for Zomedica in the last 12 months. Their average twelve-month price target is $0.30, predicting that the stock has a possible downside of 86.84%. The high price target for ZOM is $0.30 and the low price target for ZOM is $0.30. There are currently 1 buy rating for the stock, resulting in a consensus rating of “Buy.”

Zomedica has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $0.30, Zomedica has a forecasted downside of 86.8% from its current price of $2.28. Zomedica has received no research coverage in the past 90 days.

Dividend Strength: Zomedica (NYSEAMERICAN:ZOM)

Zomedica does not currently pay a dividend. Zomedica does not have a long track record of dividend growth.

Insiders buying/selling: Zomedica (NYSEAMERICAN:ZOM)

In the past three months, Zomedica insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $7,040.00 in company stock.

Earnings and Valuation of Zomedica (NYSEAMERICAN:ZOM

More latest stories: here